Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study

Clin Exp Pharmacol Physiol. 2017 Oct;44(10):1069-1071. doi: 10.1111/1440-1681.12798. Epub 2017 Aug 24.

Abstract

Our aim was to evaluate the role of urotensin II, urantide (urotensin II receptor antagonist) and relaxin-2 on the cellular expression of fibronectin as a surrogate marker for renal fibrosis. We employed LLC-PK1 renal tubular epithelial cells and assessed the influence on the fibrotic process of the above-mentioned substances by using anti-fibronectin antibodies in western blot analysis. The addition of urotensin II increased fibronectin expression. Urantide reduced the positivity for fibronectin caused by urotensin II (P<.05). The anti-fibrotic action was more evident for relaxin-2 (P<.01). Also in the model of TGF-β1-induced fibrosis, urantide and, to a greater extent, relaxin-2 were able to significantly lessen fibronectin expression (respectively, P<.05 and P<.01). In conclusion, relaxin-2 may reduce urotensin II-induced renal fibrosis.

Keywords: fibronectin; fibrosis; relaxin-2; urantide; urotensin II.

Publication types

  • Letter

MeSH terms

  • Animals
  • Disease Models, Animal
  • Fibronectins / metabolism*
  • Fibrosis
  • Gene Expression Regulation / drug effects*
  • Humans
  • Kidney / drug effects*
  • Kidney / pathology*
  • Male
  • Relaxin / pharmacology*
  • Swine
  • Urotensins / pharmacology*

Substances

  • Fibronectins
  • RLN2 protein, human
  • Urotensins
  • Relaxin
  • urotensin II